
VERO — Venus Concept Inc
NASDAQ · Healthcare · Medical Devices
$0.31
+$0.01 (+2.56%)
Venus Concept Inc (VERO) is a medical devices company listed on NASDAQ. It is led by Rajiv Kanishka Liyanaarchchie De Silva, based in 235 Yorkland Boulevard, Toronto, ON, Canada, M2J 4Y8, with about 292 employees. Venus Concept Inc., a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally. Its product portfolio includes Venus Legacy, a noninvasive device used in dermatological and general surgical procedures for females; Venus Versa, a multi-application device used in aesthetic and cosmetic procedures; Venus Versa Pro; and Venus Viva and Venus Viva MD, a portable and fractional RF system for dermatological procedures requiring ablation and resurfacing of the skin. The company also offers Venus Fiore, a device that delivers non-thermal RF combined with massage and magnetic field pulses to treat various medical conditions; Venus Bliss and Venus Bliss Max for non-invasive lipolysis of the abdomen, flanks, back, and thighs in individuals with a body mass index BMI of 30 or less; Venus Glow, a Motorized dermabrasion device used to improve skin appearance; and NeoGraft, a hair restoration technology with an automated FUE and implantation system. In addition, it provides Venus Velocity and Venus Epileve for hair removal, permanent hair reduction, and treatment of pseudofolliculitis barbae; ARTAS iX, a robotic system to assist physicians in identifying and extracting hair follicles units from the scalp during hair transplantation, creating recipient sites, and implanting the harvested hair follicles; and AI.ME an interactive, image-guided, and computer assisted system for fractional skin resurfacing. The company is headquartered in Toronto, Canada.
Latest reported VERO revenue for 2025-09-30 was $13.8M. Net income was -$22.5M. Revenue was down 12.2% from 2025-06-30 to 2025-09-30. VERO currently screens at market cap $578.2K.
Use this VERO page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the VERO quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the VERO SEC filings page. Lician reads the product cache first so this HTML stays unique to Venus Concept Inc even when a live quote feed is slow.
About Venus Concept Inc
Venus Concept Inc., a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally. Its product portfolio includes Venus Legacy, a noninvasive device used in dermatological and general surgical procedures for females; Venus Versa, a multi-application device used in aesthetic and cosmetic procedures; Venus Versa Pro; and Venus Viva and Venus Viva MD, a portable and fractional RF system for dermatological procedures requiring ablation and resurfacing of the skin. The company also offers Venus Fiore, a device that delivers non-thermal RF combined with massage and magnetic field pulses to treat various medical conditions; Venus Bliss and Venus Bliss Max for non-invasive lipolysis of the abdomen, flanks, back, and thighs in individuals with a body mass index BMI of 30 or less; Venus Glow, a Motorized dermabrasion device used to improve skin appearance; and NeoGraft, a hair restoration technology with an automated FUE and implantation system. In addition, it provides Venus Velocity and Venus Epileve for hair removal, permanent hair reduction, and treatment of pseudofolliculitis barbae; ARTAS iX, a robotic system to assist physicians in identifying and extracting hair follicles units from the scalp during hair transplantation, creating recipient sites, and implanting the harvested hair follicles; and AI.ME an interactive, image-guided, and computer assisted system for fractional skin resurfacing. The company is headquartered in Toronto, Canada.
VERO Key Statistics
Market Cap
$0.58M
Volume
1,478
Previous Close
$0.30
Day Range
$0.27 – $0.38
P/B Ratio
0.22
EPS
-$71.21
Revenue
$64.83M
Net Income
-$46.97M
Gross Profit
$0.00
Free Cash Flow
$0.00
Revenue Growth
-15.1%
Profit Margin
-72.4%
Employees
292
VERO Financials
Annual income statement in USD. Latest reported periods first.
| Line | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|
| Revenue | $64.83M | $76.35M | $99.50M | $105.62M |
| Cost of Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross Profit | $0.00 | $0.00 | $0.00 | $0.00 |
| Operating Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | -$46.97M | -$37.05M | -$43.58M | -$22.14M |
| EPS (Diluted) | -$71.21 | -$68.47 | -$9.94 | -$0.42 |
Total Assets
$68.18M
Total Debt
$0.00
Shareholders' Equity
$0.00
Cash & Equivalents
$4.27M
Operating Cash Flow
-$11.07M
Free Cash Flow
$0.00
Venus Concept Inc Company Information
- CEO & Director
- Rajiv Kanishka Liyanaarchchie De Silva
- Headquarters
- 235 Yorkland Boulevard, Toronto, ON, Canada, M2J 4Y8
- Website
- www.venus.ai
- Phone
- 877 848 8430
- IPO / Founded
- 2012-11-05
- Sector
- Healthcare
- Industry
- Medical Devices